05 Compliance

The regulatory file for L-histidine

Technical document 05 · Reviewed 2026-11-19 · L-Histidine

On this page
  1. Three markets, three instruments
  2. The European Union: outside the vitamin and mineral lists
  3. The United States: a dietary ingredient under DSHEA
  4. Contaminants: specification against law
  5. Claims and the label
  6. What the file must contain
  7. A short review checklist

L-histidine is an amino acid ingredient, not a vitamin or a mineral, so the EU food-supplement directive does not place it on the harmonised vitamin and mineral lists; member states may set the level and notification rules. In the United States it is sold as a dietary ingredient, Great Britain applies the retained framework, and Northern Ireland follows the EU. This page sets out the instruments, the contaminant arithmetic, the label questions and the documents; it does not decide the route for a destination, which the buyer's regulatory team confirms against the current text.

In one line

No single amino-acid approval covers every market: the file has to show the form, the route, the contaminant margin and the label for the destination.

Three markets, three instruments

One certificate can satisfy one market and fail another; the table names the main instruments and what each settles. The current consolidated text is the reference.

Which instrument controls what · L-histidine
MarketMain instrumentsWhat they settle
European UnionDirective 2002/46/EC; Regulations 1169/2011, 1924/2006, 2015/2283 and 2023/915Supplement framework, labelling, claims, novel-food history and contaminants
United StatesFD&C Act as amended by DSHEA; 21 CFR 111 and 101.36Dietary ingredient status, cGMP, Supplement Facts
United KingdomRetained food law and the Food Supplements Regulations 2003; Food Information Regulations 2014Permission and labelling in Great Britain; Northern Ireland follows the EU

This is a sourcing reference, not legal advice; the destination and the finished-product route decide the file.

The European Union: outside the vitamin and mineral lists

Annexes I and II to Directive 2002/46/EC list the vitamins and minerals permitted in food supplements; L-histidine is neither. The Directive still sets the labelling particulars, but the permission and the level for an amino acid come from general food law and the member state where the product is sold. Some member states set a maximum, require a notification or restrict a form; there is no single EU answer to “how much is allowed”.

The novel-food question turns on documented use before 15 May 1997; the file should carry the evidence rather than the conclusion, and the buyer's regulatory team confirms the position. Labelling follows Regulation (EU) No 1169/2011 and the supplement particulars in the Directive. L-histidine has no Nutrient Reference Value in Annex XIII, so no percentage of an NRV can be shown. Great Britain applies the retained framework and Northern Ireland the EU rules under the Windsor Framework.

The United States: a dietary ingredient under DSHEA

L-histidine is sold in the US as a dietary ingredient under section 201(ff) of the FD&C Act. For an amino acid with a pre-1994 history, the basis is normally the pre-1994 marketing route, not a new dietary ingredient notification; the supplier's file should name the basis, and the buyer confirms that it covers the finished product.

Under 21 CFR 111 the manufacturer must test the identity of each component on receipt. The Supplement Facts panel is set by 21 CFR 101.36: it declares the amount of L-histidine per serving, and because the amino acid has no Daily Value, no percentage is shown. A structure or function statement needs substantiation and the DSHEA disclaimer in 21 CFR 101.93; a disease claim is not permitted, and the FDA does not approve a label before marketing.

Contaminants: specification against law

The heavy-metal lines are specification terms, and three of them coincide with a legal maximum. A limit set at the maximum leaves nothing for analytical uncertainty, so the file should show the margin.

Catalog limits and the EU position for food supplements
ParameterCatalog limitEU legal position, as of this review
Lead (Pb)≤3 mg/kg3.0 mg/kg maximum; the catalog sits at the line
Cadmium (Cd)≤1 mg/kg1.0 mg/kg maximum; the catalog sits at the line
Mercury (Hg)≤0.1 mg/kg0.10 mg/kg maximum; the catalog sits at the line
Arsenic (As)≤2 mg/kgNo harmonised EU maximum for supplements; the line is contractual

The limits apply to the finished supplement, not only the ingredient: a compliant powder can still exceed a limit if the daily dose is high or other ingredients add metals. In the US there is no federal lead maximum; California's Proposition 65 assesses exposure per daily dose, with a maximum allowable dose level of 0.5 µg/day for lead.

Histamine is not a heavy metal, but it belongs in the file: it is one decarboxylation step from L-histidine, and a general related-substances test may not quantify it. If a histamine limit applies, write it into the specification with a method and a result. For the hydrochloride, add the chloride and water lines; the label name and dose depend on the salt form.

Claims and the label

In the EU and the UK, health claims are governed by Regulation (EC) No 1924/2006 and its retained equivalents, and a claim must appear in the register before use. As of this review the EU register carries no authorised health claim for L-histidine. A compositional statement such as “L-histidine 500 mg per capsule” describes the product, and the figure has to match the specification.

In the US the structure or function route is open with the disclaimer and rests on substantiation held by the brand owner; it does not extend to a disease. The same wording cannot be carried into the EU or the UK, where the register decides.

The declared quantity follows the form. If the drum contains the hydrochloride and the label says “L-histidine”, the declaration overstates the histidine by about 26% of the salt's weight. The grades page and the free-base-versus-hydrochloride page work through that arithmetic.

What the file must contain

  • A batch certificate that names the method and basis for each result, with the lot code matching the pack.
  • The versioned specification it was released against, naming the form and the mesh.
  • A safety data sheet, an allergen statement and a site and country-of-origin statement.
  • A novel-food statement that documents the pre-1997 use, not just the conclusion.
  • A US dietary-ingredient statement, or a notification for a genuinely new form.
  • A food-contact declaration for the pouch and liner, and a histamine statement where a limit applies.
  • A stability summary, the assigned retest period and any halal or kosher certificate.

A short review checklist

  1. Name the market, and for the EU the member state of sale.
  2. Confirm that the specification and label name the free base, not a blend or a salt.
  3. Check the destination's level rule and notification requirement, not only the EU position.
  4. Compare each contaminant limit with the legal maximum and write down the margin.
  5. Test the claim wording against the EU or GB register, or the US substantiation file.
  6. Keep the specification, the certificate and the label on the same version and lot code.

The framework for each market is set out on the EU regulatory page, the US page and the UK page. The release tests are on the COA page; the identity evidence is on the identity page; the product page carries the catalog specification; the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation